Engineered Bivalent Ligands to Bias ErbB Receptor-mediated Signaling and Phenotypes
The ErbB receptor family is dysregulated in many cancers, and its therapeutic manipulation by targeted antibodies and kinase inhibitors has resulted in effective chemotherapies. However, many malignancies remain refractory to current interventions. We describe a new approach that directs ErbB recept...
Main Authors: | Jay, Steven M. (Contributor), Kurtagic, Elma (Contributor), Alvarez, Luis M. (Contributor), De Picciotto, Seymour (Contributor), Hawkins, Jessica F. (Author), Prince, Robin N. (Contributor), Guerrero, Yadir (Contributor), Treasure, Carolyn L. (Author), Lee, Richard T. (Author), Griffith, Linda G. (Author), Sanchez, Edgar (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Center for Gynepathology Research (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Sanchez Palacios, Edgar I. (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Society for Biochemistry and Molecular Biology (ASBMB),
2012-12-18T20:14:10Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Tailoring Chimeric Ligands for Studying and Biasing ErbB Receptor Family Interactions
by: Krueger, Andrew T., et al.
Published: (2015) -
Analysis of ErbB Receptors: Regulation of ErbB-1 Kinase Activation and Localization of ErbB-4 to Membrane Microdomains
by: Thiel, Kristina Wyatt
Published: (2007) -
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
by: Diego Alvarado, et al.
Published: (2017-01-01) -
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
by: Guangyuan Li, et al.
Published: (2014-01-01) -
Ontogeny of the Neuregulin Receptor ErbB4 in the Rat Forebrain and Phenotypic Characterization of ErbB4-Deficienct Mice
by: Hau-Jie Yau, et al.
Published: (2006)